7h agoThe FlyBEARISH 34Analyst
Archived explainer. For the current picture see today's ABVX page.
Why Is ABIVAX SA ADR (ABVX) Stock Down Today?
By the Top Tier Newswire AI Desk · September 22, 2026 at 10:19 AM ET · reviewed against 8 wire stories
ABIVAX SA ADR (ABVX) is down -5.12% in the latest session. Our newswire has captured 8 stories on ABVX across 3 sources in the last 36 hours, with AI sentiment reading mixed (avg 50/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why ABVX stock is down today
ABVX stock fell 5.12% to $98.15 in early trading on September 21, 2026, following a mix of bearish analyst updates and the release of first-half 2026 financial results. The stock opened at $103.31 and steadily declined throughout the session, reaching a low of $97.68 before settling near $98.22. The move reflects investor concern over the company’s performance and revised expectations from analysts.
What Happened
The stock’s decline came after Wedbush and Truist both cut their price targets for ABVX. Wedbush reduced its target to $118 from $140, while Truist lowered its target to $151 from $155. These adjustments followed the company’s first-half 2026 financial results, which showed continued unprofitability with a trailing twelve-month (TTM) earnings per share of -5.23 and a TTM revenue decline of 59.8%. In addition, Abivax announced key leadership changes, including the appointment of Chris Rabbat as Chief Medical Officer, succeeding Fabio Cataldi. The stock also opened the session with a bearish tone, as options data had previously suggested a potential 6.0% move post-earnings.
What The Data Shows
The stock has been under pressure recently, with a downward trend of -6.0% over the last eight sessions. Trading volume was elevated at 0.6 million shares, or 0.3 times the 3-month average. The stock closed near its session low and has now printed 11 fresh 52-week lows on September 22. The broader market context included a general improvement in investor sentiment, though the Nasdaq’s weekly gains did not extend to ABVX. Meanwhile, retail chatter remained muted, with no significant social media activity reported in the last 24 hours.
What To Watch
The stock is set to report earnings on September 21, 2026, which could provide further insight into the company’s performance and strategic direction. Investors will also be watching for additional analyst coverage and how the stock reacts to the recent leadership changes and bearish price target revisions.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
ABVX by the numbers
Last: $98.15Session: -5.12%7 sessions: -5.98%Coverage: 8 stories / 3 sourcesAI sentiment: 50/100 (mixed)Mkt cap: $9.1B52w: $69.81 to $148.83
The headlines behind the move
7h agoThe FlyNEUTRAL 48Analyst
Abivax price target lowered to $151 from $155 at Truist
22h agoThe FlyBULLISH 56General
Abivax appoints Chris Rabbat as Chief Medical Officer
22h agoBusiness InsiderNEUTRAL 50General
Abivax reports 1H results
22h agoBusiness InsiderNEUTRAL 50Earnings
EQS-News: Abivax Presents Business Updates and First Half 2026 Financial Results
EQS-News: ABIVAX / Key word(s): Half Year Results Abivax Presents Business Updates and First Half 2026 Financial Results 21.09.2026 / 22:05 CET/CEST The issuer is solely responsible for the content of this announcement. Abivax...
22h agoBusiness InsiderBULLISH 55General
Abivax Presents Business Updates and First Half 2026 Financial Results
Abivax Presents Business Updates and First Half 2026 Financial Results Chris Rabbat to succeed Fabio Cataldi as Chief Medical Officer; Tim Kelly appointed Chief...
1d agoThe FlyBULLISH 56Earnings
Abivax options imply 6.0% move in share price post-earnings
1d agoSeeking AlphaNEUTRAL 50Earnings
Here are the major earnings after the close Monday
Major earnings expected after the bell on Monday include:ABIVAX Societe Anonyme (ABVX)For Seeking Alpha
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on ABVX: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier ABVX move explainers: 2026-09-22